PARP inhibitors for HRR-deficient metastatic castration-resistant prostate cancer: mechanisms and clinical strategies
Author:
Naixiong Peng,Dong Chen,Minlong Yang,Changchun Zeng,Wei Li
Publication:
European Journal of Pharmaceutical Sciences
© 2025 The Authors. Published by Elsevier B.V.